Cargando…

Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury

BACKGROUND: Pregnane X receptor (PXR) regulates the expression of drug-metabolizing enzymes and transport enzymes. NF-κB not only plays a role in liver homeostasis and injury-healing processes by regulating inflammatory responses but may also regulate the transcription of PXR. Currently, genetic pol...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jingwei, Zhao, Zhenzhen, Bai, Hao, Wang, Minjin, Jiao, Lin, Peng, Wu, Wu, Tao, Liu, Tangyuheng, Chen, Hao, Song, Xingbo, Wu, Lijuan, Hu, Xuejiao, Wu, Qian, Zhou, Juan, Song, Jiajia, Lyv, Mengyuan, Ying, Binwu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6730870/
https://www.ncbi.nlm.nih.gov/pubmed/31490979
http://dx.doi.org/10.1371/journal.pone.0222033
_version_ 1783449592970346496
author Zhang, Jingwei
Zhao, Zhenzhen
Bai, Hao
Wang, Minjin
Jiao, Lin
Peng, Wu
Wu, Tao
Liu, Tangyuheng
Chen, Hao
Song, Xingbo
Wu, Lijuan
Hu, Xuejiao
Wu, Qian
Zhou, Juan
Song, Jiajia
Lyv, Mengyuan
Ying, Binwu
author_facet Zhang, Jingwei
Zhao, Zhenzhen
Bai, Hao
Wang, Minjin
Jiao, Lin
Peng, Wu
Wu, Tao
Liu, Tangyuheng
Chen, Hao
Song, Xingbo
Wu, Lijuan
Hu, Xuejiao
Wu, Qian
Zhou, Juan
Song, Jiajia
Lyv, Mengyuan
Ying, Binwu
author_sort Zhang, Jingwei
collection PubMed
description BACKGROUND: Pregnane X receptor (PXR) regulates the expression of drug-metabolizing enzymes and transport enzymes. NF-κB not only plays a role in liver homeostasis and injury-healing processes by regulating inflammatory responses but may also regulate the transcription of PXR. Currently, genetic polymorphisms in PXR are associated with adverse drug effects. Because little is known about the association between NF-κB1 genetic polymorphisms and adverse drug reactions, we explored the association between PXR and NF-κB1 single nucleotide polymorphisms (SNPs) and susceptibility to anti-tuberculosis drug-induced liver injury (ATDILI). MATERIALS AND METHODS: A total of 746 tuberculosis patients (118 with ATDILI and 628 without ATDILI) were prospectively enrolled at West China Hospital between December 2014 and April 2018. Nine selected SNPs (rs3814055, rs13059232, rs7643645 and rs3732360 in PXR and rs78872571, rs4647992, rs60371688, rs1598861 and rs3774959 in NF-κB1) were genotyped with a custom-designed 2x48-plex SNP Scan TM Kit. The frequencies of the alleles, genotypes and genetic models of the variants were compared between patients with or without ATDILI, while joint effect analysis of the SNP-SNP interactions was performed using multiplicative and additive models. The odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were calculated. RESULTS: The T allele of rs3814055 in PXR was associated with a decreased risk for ATDILI (OR 0.61; 95% CI: 0.42–0.89, p = 0.0098). The T alleles of rs78872571 and rs4647992 in NF-κB1 were significantly associated with an increased risk for ATDILI (OR 1.91; 95% CI: 1.06–3.43, p = 0.028 and OR 1.81; 1.06–3.10, p = 0.029, respectively). The allele, genotype and genetic model frequencies were similar in the two groups for the other six SNPs (all P>0.05). There were no multiplicative or additive interactions between the SNPs. CONCLUSION: Our study is the first to reveal that rs3814055 variants in PXR and rs78872571 and rs4647992 variants in NF-κB1 are associated with susceptibility to ATDILI caused by first-line anti-tuberculosis combination treatment in the Han Chinese population.
format Online
Article
Text
id pubmed-6730870
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-67308702019-09-16 Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury Zhang, Jingwei Zhao, Zhenzhen Bai, Hao Wang, Minjin Jiao, Lin Peng, Wu Wu, Tao Liu, Tangyuheng Chen, Hao Song, Xingbo Wu, Lijuan Hu, Xuejiao Wu, Qian Zhou, Juan Song, Jiajia Lyv, Mengyuan Ying, Binwu PLoS One Research Article BACKGROUND: Pregnane X receptor (PXR) regulates the expression of drug-metabolizing enzymes and transport enzymes. NF-κB not only plays a role in liver homeostasis and injury-healing processes by regulating inflammatory responses but may also regulate the transcription of PXR. Currently, genetic polymorphisms in PXR are associated with adverse drug effects. Because little is known about the association between NF-κB1 genetic polymorphisms and adverse drug reactions, we explored the association between PXR and NF-κB1 single nucleotide polymorphisms (SNPs) and susceptibility to anti-tuberculosis drug-induced liver injury (ATDILI). MATERIALS AND METHODS: A total of 746 tuberculosis patients (118 with ATDILI and 628 without ATDILI) were prospectively enrolled at West China Hospital between December 2014 and April 2018. Nine selected SNPs (rs3814055, rs13059232, rs7643645 and rs3732360 in PXR and rs78872571, rs4647992, rs60371688, rs1598861 and rs3774959 in NF-κB1) were genotyped with a custom-designed 2x48-plex SNP Scan TM Kit. The frequencies of the alleles, genotypes and genetic models of the variants were compared between patients with or without ATDILI, while joint effect analysis of the SNP-SNP interactions was performed using multiplicative and additive models. The odds ratios (ORs) and the corresponding 95% confidence intervals (CIs) were calculated. RESULTS: The T allele of rs3814055 in PXR was associated with a decreased risk for ATDILI (OR 0.61; 95% CI: 0.42–0.89, p = 0.0098). The T alleles of rs78872571 and rs4647992 in NF-κB1 were significantly associated with an increased risk for ATDILI (OR 1.91; 95% CI: 1.06–3.43, p = 0.028 and OR 1.81; 1.06–3.10, p = 0.029, respectively). The allele, genotype and genetic model frequencies were similar in the two groups for the other six SNPs (all P>0.05). There were no multiplicative or additive interactions between the SNPs. CONCLUSION: Our study is the first to reveal that rs3814055 variants in PXR and rs78872571 and rs4647992 variants in NF-κB1 are associated with susceptibility to ATDILI caused by first-line anti-tuberculosis combination treatment in the Han Chinese population. Public Library of Science 2019-09-06 /pmc/articles/PMC6730870/ /pubmed/31490979 http://dx.doi.org/10.1371/journal.pone.0222033 Text en © 2019 Zhang et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Zhang, Jingwei
Zhao, Zhenzhen
Bai, Hao
Wang, Minjin
Jiao, Lin
Peng, Wu
Wu, Tao
Liu, Tangyuheng
Chen, Hao
Song, Xingbo
Wu, Lijuan
Hu, Xuejiao
Wu, Qian
Zhou, Juan
Song, Jiajia
Lyv, Mengyuan
Ying, Binwu
Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury
title Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury
title_full Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury
title_fullStr Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury
title_full_unstemmed Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury
title_short Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury
title_sort genetic polymorphisms in pxr and nf-κb1 influence susceptibility to anti-tuberculosis drug-induced liver injury
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6730870/
https://www.ncbi.nlm.nih.gov/pubmed/31490979
http://dx.doi.org/10.1371/journal.pone.0222033
work_keys_str_mv AT zhangjingwei geneticpolymorphismsinpxrandnfkb1influencesusceptibilitytoantituberculosisdruginducedliverinjury
AT zhaozhenzhen geneticpolymorphismsinpxrandnfkb1influencesusceptibilitytoantituberculosisdruginducedliverinjury
AT baihao geneticpolymorphismsinpxrandnfkb1influencesusceptibilitytoantituberculosisdruginducedliverinjury
AT wangminjin geneticpolymorphismsinpxrandnfkb1influencesusceptibilitytoantituberculosisdruginducedliverinjury
AT jiaolin geneticpolymorphismsinpxrandnfkb1influencesusceptibilitytoantituberculosisdruginducedliverinjury
AT pengwu geneticpolymorphismsinpxrandnfkb1influencesusceptibilitytoantituberculosisdruginducedliverinjury
AT wutao geneticpolymorphismsinpxrandnfkb1influencesusceptibilitytoantituberculosisdruginducedliverinjury
AT liutangyuheng geneticpolymorphismsinpxrandnfkb1influencesusceptibilitytoantituberculosisdruginducedliverinjury
AT chenhao geneticpolymorphismsinpxrandnfkb1influencesusceptibilitytoantituberculosisdruginducedliverinjury
AT songxingbo geneticpolymorphismsinpxrandnfkb1influencesusceptibilitytoantituberculosisdruginducedliverinjury
AT wulijuan geneticpolymorphismsinpxrandnfkb1influencesusceptibilitytoantituberculosisdruginducedliverinjury
AT huxuejiao geneticpolymorphismsinpxrandnfkb1influencesusceptibilitytoantituberculosisdruginducedliverinjury
AT wuqian geneticpolymorphismsinpxrandnfkb1influencesusceptibilitytoantituberculosisdruginducedliverinjury
AT zhoujuan geneticpolymorphismsinpxrandnfkb1influencesusceptibilitytoantituberculosisdruginducedliverinjury
AT songjiajia geneticpolymorphismsinpxrandnfkb1influencesusceptibilitytoantituberculosisdruginducedliverinjury
AT lyvmengyuan geneticpolymorphismsinpxrandnfkb1influencesusceptibilitytoantituberculosisdruginducedliverinjury
AT yingbinwu geneticpolymorphismsinpxrandnfkb1influencesusceptibilitytoantituberculosisdruginducedliverinjury